If approved, youll get your medication and ongoing support
The STEP 1 trial showed that 86.4 percent of participants achieved at least 5 percent weight loss, 69.1 percent reached 10 percent, 50.5 percent hit 15 percent, and 32 percent achieved 20 percent or greater weight loss
To view or add a comment, sign in Medicare GLP-1 Bridge Program Explained The proposed Medicare GLP-1 Bridge Program is drawing attention for its potential impact on access to obesity and diabetes treatments
Compounded BioBoost Plus a non-GLP-1 option $289* per 30ml vial Includes: 1ml dose per week for 30 weeks All syringes All alcohol prep pads Unlimited in-person or virtual visits with licensed healthcare providers Free discreet shipping No hidden fees Book an appointment and ask about our other weight loss options
In fact, 6% of the US population (about 1 in 16 people) are currently taking GLP-1 medications
These are often caused by a mild sensitivity to the needle or the preservative in the medication